MOLECULAR THERAPY

[GetPortalCommentsPageByObjectIdResponse(id=2096243, encodeId=dfdc20962430b, content=“decision in process ”状态持续三个多月了，目前状态仍没变，太慢了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ZFfPncQiciaRyVVUjF0PRzQ1t0TgDowkY8QPicQWdvhIx2xVh3uhUOhiasCY6OFTyUekN3mibibE47NMLUmMPeciaEbAw/132, createdBy=5efa5254782, createdName=wshjucduf, createdTime=Wed Oct 26 11:27:14 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2221970, encodeId=767e22219e0ab, content=审稿巨慢，从投稿到 with editor就等了将近一个月，目前还没有Under Review可以发邮件催吗
, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41e79432453, createdName=ms8000001283157654, createdTime=Thu Aug 22 21:27:19 CST 2024, time=2024-08-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2276267, encodeId=46ff22e626769, content=审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：心血管
经验分享：请教各位投稿时候，选择特刊那不能选择none呢，是现在不接受普通投稿吗？发了邮件杂志社也没回，咋回事，有人帮忙解答吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJowicLVgt4uscELibnHsWdmOSt7ADiaGcBSAYFsiccbpaxW1rwicywrcjE9tTq1pic9vp2sibRpxzo1e4Zg/0, createdBy=92272143173, createdName=bana, createdTime=Wed Aug 06 19:16:20 CST 2025, time=2025-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2227865, encodeId=725f222e86564, content=审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：溶瘤病毒
经验分享：请问这个杂志拒稿都会推荐转投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e612474688, createdName=12445c2em61(暂无昵称), createdTime=Thu Sep 26 17:43:52 CST 2024, time=2024-09-26, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2114100, encodeId=6a40211410032, content=垃圾杂志。都是Betty那一个人说了算，非常主观得一个杂志，不怎么看peer review 结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efd66150329, createdName=ms3000000510280882, createdTime=Sat Feb 11 13:30:35 CST 2023, time=2023-02-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2208346, encodeId=2dc4220834672, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5dd15563477, createdName=ms4000001326812484, createdTime=Tue Jun 04 21:49:02 CST 2024, time=2024-06-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1095565, encodeId=78981095565ff, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078227, encodeId=15c810e8227fd, content=文章已经pre-accept20多天了，现在还是没有显示accepted，pre-accept后让上传了the final revision后，状态就一直维持在“Revised submitted”，发了邮件 也没有回复，请问有人在MT投稿遇到过这种情况么 需要再次发邮件问一下子么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211208/22a3084af9a846fab54e5c73fa504f6e/d0434724da834fbda3d95ddcd01c5f3a.PNG, createdBy=ca9a2193900, createdName=1209ce3em25(暂无昵称), createdTime=Wed Dec 08 22:12:29 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584148, encodeId=04035841486b, content=今年大概可以达到9左右，明年估计可以破10180****1320暂无昵称 2020-01-20 00:00:00 发表:
这次revise回去，2020系统重新更换了，估计主刊是要开始走高端路线。后面会比较难，冲10无悬念。, beContent=180****1320暂无昵称 2020-01-20 00:00:00 发表:

这次revise回去，2020系统重新更换了，估计主刊是要开始走高端路线。后面会比较难，冲10无悬念。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73ea1969766, createdName=∠※∠※, createdTime=Sun Feb 02 00:00:00 CST 2020, time=2020-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124736, encodeId=6f762124e3679, content=审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：临床药物
经验分享：请问外审4个月没有结果，正常吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21ee1990148, createdName=1e1a21cem55(暂无匿称), createdTime=Mon Apr 10 09:27:17 CST 2023, time=2023-04-10, status=1, ipAttribution=广东省)]

2022-10-26

wshjucduf

“decision in process ”状态持续三个多月了，目前状态仍没变，太慢了！

263

8

举报

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2096243, encodeId=dfdc20962430b, content=“decision in process ”状态持续三个多月了，目前状态仍没变，太慢了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ZFfPncQiciaRyVVUjF0PRzQ1t0TgDowkY8QPicQWdvhIx2xVh3uhUOhiasCY6OFTyUekN3mibibE47NMLUmMPeciaEbAw/132, createdBy=5efa5254782, createdName=wshjucduf, createdTime=Wed Oct 26 11:27:14 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2221970, encodeId=767e22219e0ab, content=审稿巨慢，从投稿到 with editor就等了将近一个月，目前还没有Under Review可以发邮件催吗
, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41e79432453, createdName=ms8000001283157654, createdTime=Thu Aug 22 21:27:19 CST 2024, time=2024-08-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2276267, encodeId=46ff22e626769, content=审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：心血管
经验分享：请教各位投稿时候，选择特刊那不能选择none呢，是现在不接受普通投稿吗？发了邮件杂志社也没回，咋回事，有人帮忙解答吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJowicLVgt4uscELibnHsWdmOSt7ADiaGcBSAYFsiccbpaxW1rwicywrcjE9tTq1pic9vp2sibRpxzo1e4Zg/0, createdBy=92272143173, createdName=bana, createdTime=Wed Aug 06 19:16:20 CST 2025, time=2025-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2227865, encodeId=725f222e86564, content=审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：溶瘤病毒
经验分享：请问这个杂志拒稿都会推荐转投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e612474688, createdName=12445c2em61(暂无昵称), createdTime=Thu Sep 26 17:43:52 CST 2024, time=2024-09-26, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2114100, encodeId=6a40211410032, content=垃圾杂志。都是Betty那一个人说了算，非常主观得一个杂志，不怎么看peer review 结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efd66150329, createdName=ms3000000510280882, createdTime=Sat Feb 11 13:30:35 CST 2023, time=2023-02-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2208346, encodeId=2dc4220834672, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5dd15563477, createdName=ms4000001326812484, createdTime=Tue Jun 04 21:49:02 CST 2024, time=2024-06-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1095565, encodeId=78981095565ff, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078227, encodeId=15c810e8227fd, content=文章已经pre-accept20多天了，现在还是没有显示accepted，pre-accept后让上传了the final revision后，状态就一直维持在“Revised submitted”，发了邮件 也没有回复，请问有人在MT投稿遇到过这种情况么 需要再次发邮件问一下子么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211208/22a3084af9a846fab54e5c73fa504f6e/d0434724da834fbda3d95ddcd01c5f3a.PNG, createdBy=ca9a2193900, createdName=1209ce3em25(暂无昵称), createdTime=Wed Dec 08 22:12:29 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584148, encodeId=04035841486b, content=今年大概可以达到9左右，明年估计可以破10180****1320暂无昵称 2020-01-20 00:00:00 发表:
这次revise回去，2020系统重新更换了，估计主刊是要开始走高端路线。后面会比较难，冲10无悬念。, beContent=180****1320暂无昵称 2020-01-20 00:00:00 发表:

这次revise回去，2020系统重新更换了，估计主刊是要开始走高端路线。后面会比较难，冲10无悬念。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73ea1969766, createdName=∠※∠※, createdTime=Sun Feb 02 00:00:00 CST 2020, time=2020-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124736, encodeId=6f762124e3679, content=审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：临床药物
经验分享：请问外审4个月没有结果，正常吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21ee1990148, createdName=1e1a21cem55(暂无匿称), createdTime=Mon Apr 10 09:27:17 CST 2023, time=2023-04-10, status=1, ipAttribution=广东省)]

2024-08-22

ms8000001283157654

来自四川省

审稿巨慢，从投稿到 with editor就等了将近一个月，目前还没有Under Review可以发邮件催吗

96

3

举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2096243, encodeId=dfdc20962430b, content=“decision in process ”状态持续三个多月了，目前状态仍没变，太慢了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ZFfPncQiciaRyVVUjF0PRzQ1t0TgDowkY8QPicQWdvhIx2xVh3uhUOhiasCY6OFTyUekN3mibibE47NMLUmMPeciaEbAw/132, createdBy=5efa5254782, createdName=wshjucduf, createdTime=Wed Oct 26 11:27:14 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2221970, encodeId=767e22219e0ab, content=审稿巨慢，从投稿到 with editor就等了将近一个月，目前还没有Under Review可以发邮件催吗
, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41e79432453, createdName=ms8000001283157654, createdTime=Thu Aug 22 21:27:19 CST 2024, time=2024-08-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2276267, encodeId=46ff22e626769, content=审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：心血管
经验分享：请教各位投稿时候，选择特刊那不能选择none呢，是现在不接受普通投稿吗？发了邮件杂志社也没回，咋回事，有人帮忙解答吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJowicLVgt4uscELibnHsWdmOSt7ADiaGcBSAYFsiccbpaxW1rwicywrcjE9tTq1pic9vp2sibRpxzo1e4Zg/0, createdBy=92272143173, createdName=bana, createdTime=Wed Aug 06 19:16:20 CST 2025, time=2025-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2227865, encodeId=725f222e86564, content=审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：溶瘤病毒
经验分享：请问这个杂志拒稿都会推荐转投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e612474688, createdName=12445c2em61(暂无昵称), createdTime=Thu Sep 26 17:43:52 CST 2024, time=2024-09-26, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2114100, encodeId=6a40211410032, content=垃圾杂志。都是Betty那一个人说了算，非常主观得一个杂志，不怎么看peer review 结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efd66150329, createdName=ms3000000510280882, createdTime=Sat Feb 11 13:30:35 CST 2023, time=2023-02-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2208346, encodeId=2dc4220834672, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5dd15563477, createdName=ms4000001326812484, createdTime=Tue Jun 04 21:49:02 CST 2024, time=2024-06-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1095565, encodeId=78981095565ff, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078227, encodeId=15c810e8227fd, content=文章已经pre-accept20多天了，现在还是没有显示accepted，pre-accept后让上传了the final revision后，状态就一直维持在“Revised submitted”，发了邮件 也没有回复，请问有人在MT投稿遇到过这种情况么 需要再次发邮件问一下子么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211208/22a3084af9a846fab54e5c73fa504f6e/d0434724da834fbda3d95ddcd01c5f3a.PNG, createdBy=ca9a2193900, createdName=1209ce3em25(暂无昵称), createdTime=Wed Dec 08 22:12:29 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584148, encodeId=04035841486b, content=今年大概可以达到9左右，明年估计可以破10180****1320暂无昵称 2020-01-20 00:00:00 发表:
这次revise回去，2020系统重新更换了，估计主刊是要开始走高端路线。后面会比较难，冲10无悬念。, beContent=180****1320暂无昵称 2020-01-20 00:00:00 发表:

这次revise回去，2020系统重新更换了，估计主刊是要开始走高端路线。后面会比较难，冲10无悬念。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73ea1969766, createdName=∠※∠※, createdTime=Sun Feb 02 00:00:00 CST 2020, time=2020-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124736, encodeId=6f762124e3679, content=审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：临床药物
经验分享：请问外审4个月没有结果，正常吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21ee1990148, createdName=1e1a21cem55(暂无匿称), createdTime=Mon Apr 10 09:27:17 CST 2023, time=2023-04-10, status=1, ipAttribution=广东省)]

2025-08-06

bana

审稿速度:1.0 | 投稿命中率:25.0偏重的研究方向：心血管经验分享：请教各位投稿时候，选择特刊那不能选择none呢，是现在不接受普通投稿吗？发了邮件杂志社也没回，咋回事，有人帮忙解答吗？

26

0

举报

[GetPortalCommentsPageByObjectIdResponse(id=2096243, encodeId=dfdc20962430b, content=“decision in process ”状态持续三个多月了，目前状态仍没变，太慢了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ZFfPncQiciaRyVVUjF0PRzQ1t0TgDowkY8QPicQWdvhIx2xVh3uhUOhiasCY6OFTyUekN3mibibE47NMLUmMPeciaEbAw/132, createdBy=5efa5254782, createdName=wshjucduf, createdTime=Wed Oct 26 11:27:14 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2221970, encodeId=767e22219e0ab, content=审稿巨慢，从投稿到 with editor就等了将近一个月，目前还没有Under Review可以发邮件催吗
, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41e79432453, createdName=ms8000001283157654, createdTime=Thu Aug 22 21:27:19 CST 2024, time=2024-08-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2276267, encodeId=46ff22e626769, content=审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：心血管
经验分享：请教各位投稿时候，选择特刊那不能选择none呢，是现在不接受普通投稿吗？发了邮件杂志社也没回，咋回事，有人帮忙解答吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJowicLVgt4uscELibnHsWdmOSt7ADiaGcBSAYFsiccbpaxW1rwicywrcjE9tTq1pic9vp2sibRpxzo1e4Zg/0, createdBy=92272143173, createdName=bana, createdTime=Wed Aug 06 19:16:20 CST 2025, time=2025-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2227865, encodeId=725f222e86564, content=审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：溶瘤病毒
经验分享：请问这个杂志拒稿都会推荐转投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e612474688, createdName=12445c2em61(暂无昵称), createdTime=Thu Sep 26 17:43:52 CST 2024, time=2024-09-26, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2114100, encodeId=6a40211410032, content=垃圾杂志。都是Betty那一个人说了算，非常主观得一个杂志，不怎么看peer review 结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efd66150329, createdName=ms3000000510280882, createdTime=Sat Feb 11 13:30:35 CST 2023, time=2023-02-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2208346, encodeId=2dc4220834672, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5dd15563477, createdName=ms4000001326812484, createdTime=Tue Jun 04 21:49:02 CST 2024, time=2024-06-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1095565, encodeId=78981095565ff, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078227, encodeId=15c810e8227fd, content=文章已经pre-accept20多天了，现在还是没有显示accepted，pre-accept后让上传了the final revision后，状态就一直维持在“Revised submitted”，发了邮件 也没有回复，请问有人在MT投稿遇到过这种情况么 需要再次发邮件问一下子么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211208/22a3084af9a846fab54e5c73fa504f6e/d0434724da834fbda3d95ddcd01c5f3a.PNG, createdBy=ca9a2193900, createdName=1209ce3em25(暂无昵称), createdTime=Wed Dec 08 22:12:29 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584148, encodeId=04035841486b, content=今年大概可以达到9左右，明年估计可以破10180****1320暂无昵称 2020-01-20 00:00:00 发表:
这次revise回去，2020系统重新更换了，估计主刊是要开始走高端路线。后面会比较难，冲10无悬念。, beContent=180****1320暂无昵称 2020-01-20 00:00:00 发表:

这次revise回去，2020系统重新更换了，估计主刊是要开始走高端路线。后面会比较难，冲10无悬念。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73ea1969766, createdName=∠※∠※, createdTime=Sun Feb 02 00:00:00 CST 2020, time=2020-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124736, encodeId=6f762124e3679, content=审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：临床药物
经验分享：请问外审4个月没有结果，正常吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21ee1990148, createdName=1e1a21cem55(暂无匿称), createdTime=Mon Apr 10 09:27:17 CST 2023, time=2023-04-10, status=1, ipAttribution=广东省)]

2024-09-26

12445c2em61(暂无昵称)

来自陕西省

审稿速度:1.0 | 投稿命中率:25.0偏重的研究方向：溶瘤病毒经验分享：请问这个杂志拒稿都会推荐转投吗？

77

0

举报

[GetPortalCommentsPageByObjectIdResponse(id=2096243, encodeId=dfdc20962430b, content=“decision in process ”状态持续三个多月了，目前状态仍没变，太慢了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ZFfPncQiciaRyVVUjF0PRzQ1t0TgDowkY8QPicQWdvhIx2xVh3uhUOhiasCY6OFTyUekN3mibibE47NMLUmMPeciaEbAw/132, createdBy=5efa5254782, createdName=wshjucduf, createdTime=Wed Oct 26 11:27:14 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2221970, encodeId=767e22219e0ab, content=审稿巨慢，从投稿到 with editor就等了将近一个月，目前还没有Under Review可以发邮件催吗
, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41e79432453, createdName=ms8000001283157654, createdTime=Thu Aug 22 21:27:19 CST 2024, time=2024-08-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2276267, encodeId=46ff22e626769, content=审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：心血管
经验分享：请教各位投稿时候，选择特刊那不能选择none呢，是现在不接受普通投稿吗？发了邮件杂志社也没回，咋回事，有人帮忙解答吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJowicLVgt4uscELibnHsWdmOSt7ADiaGcBSAYFsiccbpaxW1rwicywrcjE9tTq1pic9vp2sibRpxzo1e4Zg/0, createdBy=92272143173, createdName=bana, createdTime=Wed Aug 06 19:16:20 CST 2025, time=2025-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2227865, encodeId=725f222e86564, content=审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：溶瘤病毒
经验分享：请问这个杂志拒稿都会推荐转投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e612474688, createdName=12445c2em61(暂无昵称), createdTime=Thu Sep 26 17:43:52 CST 2024, time=2024-09-26, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2114100, encodeId=6a40211410032, content=垃圾杂志。都是Betty那一个人说了算，非常主观得一个杂志，不怎么看peer review 结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efd66150329, createdName=ms3000000510280882, createdTime=Sat Feb 11 13:30:35 CST 2023, time=2023-02-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2208346, encodeId=2dc4220834672, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5dd15563477, createdName=ms4000001326812484, createdTime=Tue Jun 04 21:49:02 CST 2024, time=2024-06-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1095565, encodeId=78981095565ff, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078227, encodeId=15c810e8227fd, content=文章已经pre-accept20多天了，现在还是没有显示accepted，pre-accept后让上传了the final revision后，状态就一直维持在“Revised submitted”，发了邮件 也没有回复，请问有人在MT投稿遇到过这种情况么 需要再次发邮件问一下子么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211208/22a3084af9a846fab54e5c73fa504f6e/d0434724da834fbda3d95ddcd01c5f3a.PNG, createdBy=ca9a2193900, createdName=1209ce3em25(暂无昵称), createdTime=Wed Dec 08 22:12:29 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584148, encodeId=04035841486b, content=今年大概可以达到9左右，明年估计可以破10180****1320暂无昵称 2020-01-20 00:00:00 发表:
这次revise回去，2020系统重新更换了，估计主刊是要开始走高端路线。后面会比较难，冲10无悬念。, beContent=180****1320暂无昵称 2020-01-20 00:00:00 发表:

这次revise回去，2020系统重新更换了，估计主刊是要开始走高端路线。后面会比较难，冲10无悬念。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73ea1969766, createdName=∠※∠※, createdTime=Sun Feb 02 00:00:00 CST 2020, time=2020-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124736, encodeId=6f762124e3679, content=审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：临床药物
经验分享：请问外审4个月没有结果，正常吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21ee1990148, createdName=1e1a21cem55(暂无匿称), createdTime=Mon Apr 10 09:27:17 CST 2023, time=2023-04-10, status=1, ipAttribution=广东省)]

2023-02-11

ms3000000510280882

来自广东省

垃圾杂志。都是Betty那一个人说了算，非常主观得一个杂志，不怎么看peer review 结果。

167

3

举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2096243, encodeId=dfdc20962430b, content=“decision in process ”状态持续三个多月了，目前状态仍没变，太慢了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ZFfPncQiciaRyVVUjF0PRzQ1t0TgDowkY8QPicQWdvhIx2xVh3uhUOhiasCY6OFTyUekN3mibibE47NMLUmMPeciaEbAw/132, createdBy=5efa5254782, createdName=wshjucduf, createdTime=Wed Oct 26 11:27:14 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2221970, encodeId=767e22219e0ab, content=审稿巨慢，从投稿到 with editor就等了将近一个月，目前还没有Under Review可以发邮件催吗
, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41e79432453, createdName=ms8000001283157654, createdTime=Thu Aug 22 21:27:19 CST 2024, time=2024-08-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2276267, encodeId=46ff22e626769, content=审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：心血管
经验分享：请教各位投稿时候，选择特刊那不能选择none呢，是现在不接受普通投稿吗？发了邮件杂志社也没回，咋回事，有人帮忙解答吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJowicLVgt4uscELibnHsWdmOSt7ADiaGcBSAYFsiccbpaxW1rwicywrcjE9tTq1pic9vp2sibRpxzo1e4Zg/0, createdBy=92272143173, createdName=bana, createdTime=Wed Aug 06 19:16:20 CST 2025, time=2025-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2227865, encodeId=725f222e86564, content=审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：溶瘤病毒
经验分享：请问这个杂志拒稿都会推荐转投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e612474688, createdName=12445c2em61(暂无昵称), createdTime=Thu Sep 26 17:43:52 CST 2024, time=2024-09-26, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2114100, encodeId=6a40211410032, content=垃圾杂志。都是Betty那一个人说了算，非常主观得一个杂志，不怎么看peer review 结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efd66150329, createdName=ms3000000510280882, createdTime=Sat Feb 11 13:30:35 CST 2023, time=2023-02-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2208346, encodeId=2dc4220834672, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5dd15563477, createdName=ms4000001326812484, createdTime=Tue Jun 04 21:49:02 CST 2024, time=2024-06-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1095565, encodeId=78981095565ff, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078227, encodeId=15c810e8227fd, content=文章已经pre-accept20多天了，现在还是没有显示accepted，pre-accept后让上传了the final revision后，状态就一直维持在“Revised submitted”，发了邮件 也没有回复，请问有人在MT投稿遇到过这种情况么 需要再次发邮件问一下子么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211208/22a3084af9a846fab54e5c73fa504f6e/d0434724da834fbda3d95ddcd01c5f3a.PNG, createdBy=ca9a2193900, createdName=1209ce3em25(暂无昵称), createdTime=Wed Dec 08 22:12:29 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584148, encodeId=04035841486b, content=今年大概可以达到9左右，明年估计可以破10180****1320暂无昵称 2020-01-20 00:00:00 发表:
这次revise回去，2020系统重新更换了，估计主刊是要开始走高端路线。后面会比较难，冲10无悬念。, beContent=180****1320暂无昵称 2020-01-20 00:00:00 发表:

这次revise回去，2020系统重新更换了，估计主刊是要开始走高端路线。后面会比较难，冲10无悬念。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73ea1969766, createdName=∠※∠※, createdTime=Sun Feb 02 00:00:00 CST 2020, time=2020-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124736, encodeId=6f762124e3679, content=审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：临床药物
经验分享：请问外审4个月没有结果，正常吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21ee1990148, createdName=1e1a21cem55(暂无匿称), createdTime=Mon Apr 10 09:27:17 CST 2023, time=2023-04-10, status=1, ipAttribution=广东省)]

2024-06-04

ms4000001326812484

来自四川省

无

127

0

举报

[GetPortalCommentsPageByObjectIdResponse(id=2096243, encodeId=dfdc20962430b, content=“decision in process ”状态持续三个多月了，目前状态仍没变，太慢了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ZFfPncQiciaRyVVUjF0PRzQ1t0TgDowkY8QPicQWdvhIx2xVh3uhUOhiasCY6OFTyUekN3mibibE47NMLUmMPeciaEbAw/132, createdBy=5efa5254782, createdName=wshjucduf, createdTime=Wed Oct 26 11:27:14 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2221970, encodeId=767e22219e0ab, content=审稿巨慢，从投稿到 with editor就等了将近一个月，目前还没有Under Review可以发邮件催吗
, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41e79432453, createdName=ms8000001283157654, createdTime=Thu Aug 22 21:27:19 CST 2024, time=2024-08-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2276267, encodeId=46ff22e626769, content=审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：心血管
经验分享：请教各位投稿时候，选择特刊那不能选择none呢，是现在不接受普通投稿吗？发了邮件杂志社也没回，咋回事，有人帮忙解答吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJowicLVgt4uscELibnHsWdmOSt7ADiaGcBSAYFsiccbpaxW1rwicywrcjE9tTq1pic9vp2sibRpxzo1e4Zg/0, createdBy=92272143173, createdName=bana, createdTime=Wed Aug 06 19:16:20 CST 2025, time=2025-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2227865, encodeId=725f222e86564, content=审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：溶瘤病毒
经验分享：请问这个杂志拒稿都会推荐转投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e612474688, createdName=12445c2em61(暂无昵称), createdTime=Thu Sep 26 17:43:52 CST 2024, time=2024-09-26, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2114100, encodeId=6a40211410032, content=垃圾杂志。都是Betty那一个人说了算，非常主观得一个杂志，不怎么看peer review 结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efd66150329, createdName=ms3000000510280882, createdTime=Sat Feb 11 13:30:35 CST 2023, time=2023-02-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2208346, encodeId=2dc4220834672, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5dd15563477, createdName=ms4000001326812484, createdTime=Tue Jun 04 21:49:02 CST 2024, time=2024-06-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1095565, encodeId=78981095565ff, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078227, encodeId=15c810e8227fd, content=文章已经pre-accept20多天了，现在还是没有显示accepted，pre-accept后让上传了the final revision后，状态就一直维持在“Revised submitted”，发了邮件 也没有回复，请问有人在MT投稿遇到过这种情况么 需要再次发邮件问一下子么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211208/22a3084af9a846fab54e5c73fa504f6e/d0434724da834fbda3d95ddcd01c5f3a.PNG, createdBy=ca9a2193900, createdName=1209ce3em25(暂无昵称), createdTime=Wed Dec 08 22:12:29 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584148, encodeId=04035841486b, content=今年大概可以达到9左右，明年估计可以破10180****1320暂无昵称 2020-01-20 00:00:00 发表:
这次revise回去，2020系统重新更换了，估计主刊是要开始走高端路线。后面会比较难，冲10无悬念。, beContent=180****1320暂无昵称 2020-01-20 00:00:00 发表:

这次revise回去，2020系统重新更换了，估计主刊是要开始走高端路线。后面会比较难，冲10无悬念。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73ea1969766, createdName=∠※∠※, createdTime=Sun Feb 02 00:00:00 CST 2020, time=2020-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124736, encodeId=6f762124e3679, content=审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：临床药物
经验分享：请问外审4个月没有结果，正常吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21ee1990148, createdName=1e1a21cem55(暂无匿称), createdTime=Mon Apr 10 09:27:17 CST 2023, time=2023-04-10, status=1, ipAttribution=广东省)]

2021-12-27

Gym璨烨

选刊时有什么原则吗？

176

2

举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2096243, encodeId=dfdc20962430b, content=“decision in process ”状态持续三个多月了，目前状态仍没变，太慢了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ZFfPncQiciaRyVVUjF0PRzQ1t0TgDowkY8QPicQWdvhIx2xVh3uhUOhiasCY6OFTyUekN3mibibE47NMLUmMPeciaEbAw/132, createdBy=5efa5254782, createdName=wshjucduf, createdTime=Wed Oct 26 11:27:14 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2221970, encodeId=767e22219e0ab, content=审稿巨慢，从投稿到 with editor就等了将近一个月，目前还没有Under Review可以发邮件催吗
, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41e79432453, createdName=ms8000001283157654, createdTime=Thu Aug 22 21:27:19 CST 2024, time=2024-08-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2276267, encodeId=46ff22e626769, content=审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：心血管
经验分享：请教各位投稿时候，选择特刊那不能选择none呢，是现在不接受普通投稿吗？发了邮件杂志社也没回，咋回事，有人帮忙解答吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJowicLVgt4uscELibnHsWdmOSt7ADiaGcBSAYFsiccbpaxW1rwicywrcjE9tTq1pic9vp2sibRpxzo1e4Zg/0, createdBy=92272143173, createdName=bana, createdTime=Wed Aug 06 19:16:20 CST 2025, time=2025-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2227865, encodeId=725f222e86564, content=审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：溶瘤病毒
经验分享：请问这个杂志拒稿都会推荐转投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e612474688, createdName=12445c2em61(暂无昵称), createdTime=Thu Sep 26 17:43:52 CST 2024, time=2024-09-26, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2114100, encodeId=6a40211410032, content=垃圾杂志。都是Betty那一个人说了算，非常主观得一个杂志，不怎么看peer review 结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efd66150329, createdName=ms3000000510280882, createdTime=Sat Feb 11 13:30:35 CST 2023, time=2023-02-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2208346, encodeId=2dc4220834672, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5dd15563477, createdName=ms4000001326812484, createdTime=Tue Jun 04 21:49:02 CST 2024, time=2024-06-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1095565, encodeId=78981095565ff, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078227, encodeId=15c810e8227fd, content=文章已经pre-accept20多天了，现在还是没有显示accepted，pre-accept后让上传了the final revision后，状态就一直维持在“Revised submitted”，发了邮件 也没有回复，请问有人在MT投稿遇到过这种情况么 需要再次发邮件问一下子么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211208/22a3084af9a846fab54e5c73fa504f6e/d0434724da834fbda3d95ddcd01c5f3a.PNG, createdBy=ca9a2193900, createdName=1209ce3em25(暂无昵称), createdTime=Wed Dec 08 22:12:29 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584148, encodeId=04035841486b, content=今年大概可以达到9左右，明年估计可以破10180****1320暂无昵称 2020-01-20 00:00:00 发表:
这次revise回去，2020系统重新更换了，估计主刊是要开始走高端路线。后面会比较难，冲10无悬念。, beContent=180****1320暂无昵称 2020-01-20 00:00:00 发表:

这次revise回去，2020系统重新更换了，估计主刊是要开始走高端路线。后面会比较难，冲10无悬念。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73ea1969766, createdName=∠※∠※, createdTime=Sun Feb 02 00:00:00 CST 2020, time=2020-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124736, encodeId=6f762124e3679, content=审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：临床药物
经验分享：请问外审4个月没有结果，正常吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21ee1990148, createdName=1e1a21cem55(暂无匿称), createdTime=Mon Apr 10 09:27:17 CST 2023, time=2023-04-10, status=1, ipAttribution=广东省)]

2021-12-08

1209ce3em25(暂无昵称)

文章已经pre-accept20多天了，现在还是没有显示accepted，pre-accept后让上传了the final revision后，状态就一直维持在“Revised submitted”，发了邮件 也没有回复，请问有人在MT投稿遇到过这种情况么 需要再次发邮件问一下子么？

209

6

举报

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2096243, encodeId=dfdc20962430b, content=“decision in process ”状态持续三个多月了，目前状态仍没变，太慢了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ZFfPncQiciaRyVVUjF0PRzQ1t0TgDowkY8QPicQWdvhIx2xVh3uhUOhiasCY6OFTyUekN3mibibE47NMLUmMPeciaEbAw/132, createdBy=5efa5254782, createdName=wshjucduf, createdTime=Wed Oct 26 11:27:14 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2221970, encodeId=767e22219e0ab, content=审稿巨慢，从投稿到 with editor就等了将近一个月，目前还没有Under Review可以发邮件催吗
, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41e79432453, createdName=ms8000001283157654, createdTime=Thu Aug 22 21:27:19 CST 2024, time=2024-08-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2276267, encodeId=46ff22e626769, content=审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：心血管
经验分享：请教各位投稿时候，选择特刊那不能选择none呢，是现在不接受普通投稿吗？发了邮件杂志社也没回，咋回事，有人帮忙解答吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJowicLVgt4uscELibnHsWdmOSt7ADiaGcBSAYFsiccbpaxW1rwicywrcjE9tTq1pic9vp2sibRpxzo1e4Zg/0, createdBy=92272143173, createdName=bana, createdTime=Wed Aug 06 19:16:20 CST 2025, time=2025-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2227865, encodeId=725f222e86564, content=审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：溶瘤病毒
经验分享：请问这个杂志拒稿都会推荐转投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e612474688, createdName=12445c2em61(暂无昵称), createdTime=Thu Sep 26 17:43:52 CST 2024, time=2024-09-26, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2114100, encodeId=6a40211410032, content=垃圾杂志。都是Betty那一个人说了算，非常主观得一个杂志，不怎么看peer review 结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efd66150329, createdName=ms3000000510280882, createdTime=Sat Feb 11 13:30:35 CST 2023, time=2023-02-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2208346, encodeId=2dc4220834672, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5dd15563477, createdName=ms4000001326812484, createdTime=Tue Jun 04 21:49:02 CST 2024, time=2024-06-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1095565, encodeId=78981095565ff, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078227, encodeId=15c810e8227fd, content=文章已经pre-accept20多天了，现在还是没有显示accepted，pre-accept后让上传了the final revision后，状态就一直维持在“Revised submitted”，发了邮件 也没有回复，请问有人在MT投稿遇到过这种情况么 需要再次发邮件问一下子么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211208/22a3084af9a846fab54e5c73fa504f6e/d0434724da834fbda3d95ddcd01c5f3a.PNG, createdBy=ca9a2193900, createdName=1209ce3em25(暂无昵称), createdTime=Wed Dec 08 22:12:29 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584148, encodeId=04035841486b, content=今年大概可以达到9左右，明年估计可以破10180****1320暂无昵称 2020-01-20 00:00:00 发表:
这次revise回去，2020系统重新更换了，估计主刊是要开始走高端路线。后面会比较难，冲10无悬念。, beContent=180****1320暂无昵称 2020-01-20 00:00:00 发表:

这次revise回去，2020系统重新更换了，估计主刊是要开始走高端路线。后面会比较难，冲10无悬念。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73ea1969766, createdName=∠※∠※, createdTime=Sun Feb 02 00:00:00 CST 2020, time=2020-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124736, encodeId=6f762124e3679, content=审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：临床药物
经验分享：请问外审4个月没有结果，正常吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21ee1990148, createdName=1e1a21cem55(暂无匿称), createdTime=Mon Apr 10 09:27:17 CST 2023, time=2023-04-10, status=1, ipAttribution=广东省)]

2020-02-02

∠※∠※

今年大概可以达到9左右，明年估计可以破10180****1320暂无昵称 2020-01-20 00:00:00 发表:这次revise回去，2020系统重新更换了，估计主刊是要开始走高端路线。后面会比较难，冲10无悬念。

180****1320暂无昵称 2020-01-20 00:00:00 发表:

这次revise回去，2020系统重新更换了，估计主刊是要开始走高端路线。后面会比较难，冲10无悬念。

243

1

举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2096243, encodeId=dfdc20962430b, content=“decision in process ”状态持续三个多月了，目前状态仍没变，太慢了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ZFfPncQiciaRyVVUjF0PRzQ1t0TgDowkY8QPicQWdvhIx2xVh3uhUOhiasCY6OFTyUekN3mibibE47NMLUmMPeciaEbAw/132, createdBy=5efa5254782, createdName=wshjucduf, createdTime=Wed Oct 26 11:27:14 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2221970, encodeId=767e22219e0ab, content=审稿巨慢，从投稿到 with editor就等了将近一个月，目前还没有Under Review可以发邮件催吗
, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41e79432453, createdName=ms8000001283157654, createdTime=Thu Aug 22 21:27:19 CST 2024, time=2024-08-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2276267, encodeId=46ff22e626769, content=审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：心血管
经验分享：请教各位投稿时候，选择特刊那不能选择none呢，是现在不接受普通投稿吗？发了邮件杂志社也没回，咋回事，有人帮忙解答吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJowicLVgt4uscELibnHsWdmOSt7ADiaGcBSAYFsiccbpaxW1rwicywrcjE9tTq1pic9vp2sibRpxzo1e4Zg/0, createdBy=92272143173, createdName=bana, createdTime=Wed Aug 06 19:16:20 CST 2025, time=2025-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2227865, encodeId=725f222e86564, content=审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：溶瘤病毒
经验分享：请问这个杂志拒稿都会推荐转投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e612474688, createdName=12445c2em61(暂无昵称), createdTime=Thu Sep 26 17:43:52 CST 2024, time=2024-09-26, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2114100, encodeId=6a40211410032, content=垃圾杂志。都是Betty那一个人说了算，非常主观得一个杂志，不怎么看peer review 结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efd66150329, createdName=ms3000000510280882, createdTime=Sat Feb 11 13:30:35 CST 2023, time=2023-02-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2208346, encodeId=2dc4220834672, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5dd15563477, createdName=ms4000001326812484, createdTime=Tue Jun 04 21:49:02 CST 2024, time=2024-06-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1095565, encodeId=78981095565ff, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078227, encodeId=15c810e8227fd, content=文章已经pre-accept20多天了，现在还是没有显示accepted，pre-accept后让上传了the final revision后，状态就一直维持在“Revised submitted”，发了邮件 也没有回复，请问有人在MT投稿遇到过这种情况么 需要再次发邮件问一下子么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211208/22a3084af9a846fab54e5c73fa504f6e/d0434724da834fbda3d95ddcd01c5f3a.PNG, createdBy=ca9a2193900, createdName=1209ce3em25(暂无昵称), createdTime=Wed Dec 08 22:12:29 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584148, encodeId=04035841486b, content=今年大概可以达到9左右，明年估计可以破10180****1320暂无昵称 2020-01-20 00:00:00 发表:
这次revise回去，2020系统重新更换了，估计主刊是要开始走高端路线。后面会比较难，冲10无悬念。, beContent=180****1320暂无昵称 2020-01-20 00:00:00 发表:

这次revise回去，2020系统重新更换了，估计主刊是要开始走高端路线。后面会比较难，冲10无悬念。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73ea1969766, createdName=∠※∠※, createdTime=Sun Feb 02 00:00:00 CST 2020, time=2020-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124736, encodeId=6f762124e3679, content=审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：临床药物
经验分享：请问外审4个月没有结果，正常吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21ee1990148, createdName=1e1a21cem55(暂无匿称), createdTime=Mon Apr 10 09:27:17 CST 2023, time=2023-04-10, status=1, ipAttribution=广东省)]

2023-04-10

1e1a21cem55(暂无匿称)

来自广东省

审稿速度:6.0 | 投稿命中率:25.0偏重的研究方向：临床药物经验分享：请问外审4个月没有结果，正常吗？谢谢

148

2

举报

展开2条回复

Previus Post
痛风专家黄川云：喝了茯苓水尿酸还高？这几种药材和尿酸相遇，尿酸立马尖叫！
Copyright © 2088 白皮书网游活动指南 All Rights Reserved.
友情链接